Here’s What Needs To Happen Next For Marijuana Stocks To Be Uplisted On Major US Exchanges

October 13, 2022 · Benzinga

President Biden’s recent announcement regarding marijuana pardons was a historic step toward cannabis legalization on the federal level. The next one is a review of cannabis’ legal status, said Bloomberg Intelligence analyst Kenneth Shea.

Biden in fact said he would ask the Attorney General and Department of Health and Human Services to review marijuana’s classification under federal law as a Schedule I drug, which happens to be the same as heroin and LSD.

BofA Securities‘ analysts Lisa K. Lewandowski and Bryan D. Spillane said recently that “it does not appear that the president could directly de/re-schedule by executive order.” They instead expect that the Senate’s composition following the elections will set the pace for reform legislation being placed on the floor for a vote.

This is how you can potentially earn $3,000 in extra income every single month…

Former leading hedge-fund trader Chris Capre is the real deal. With his simple options trading strategy, he’s helping thousands of traders by sharing his trade signals in real-time. Click Here to Get his Trades for only $0.99. ⭐⭐⭐⭐⭐ “My only regret is I wish I joined earlier…”

Meanwhile, cannabis stocks spiked following Biden’s announcement though a review of its legal status has the potential to transform those very stocks into initial public offering candidates for major exchanges, Shea said in an interview.

For example, the AdvisorShares Pure US Cannabis ETF 

MSOS jumped 34% the day Biden announced the scheduling review.

Bloomberg’s Shea said that if the Democrats hold a majority in Congress after the midterms, progress toward legalization is a plausible scenario followed by “a subsequent rush of equity capital markets activity.

“There is potential to recognize a market opportunity of up to $80 billion in the US alone and such action would send shockwaves throughout the western world,” he said.

For now, investors are not making any big moves.

“There’s not a lot of institutional buying and trading because they don’t want to be perceived as abetting the industry,” Shea said. “For companies that have sound business models and want to gain respect over time, they need to be uplisted to get the respect and liquidity they need.” Full Story

In category:Stock Market
Next Post

10 Best Psychedelic Stocks to Buy According to Hedge Funds

In this article, we discuss 10 best psychedelic stocks to buy according to hedge funds. If you want to see more stocks in this selection, check out 5 Best Psychedelic Stocks to Buy According to Hedge Funds.  Data Bridge Market Research predicts that…
Read
Random Post

Rescheduling marijuana would liberate plant-touching firms from Section 280E

As the co-founder and CEO of Capitol Wellness Solutions in Baton Rouge, Louisiana, Randy Mire runs one of only 10 companies awarded a license to sell medical marijuana in the southern state. A change in state law that went into…
Read
Random Post

Cannabis Arrests Down as DEA Seizes Six Million Plants in 2022

The US Drug Enforcement Administration and its law enforcement partners arrested fewer people for cannabis-related offenses in 2022 compared to the previous year, according to annual data from the federal agency. The DEA also seized nearly 6 million cannabis plants…
Read
Random Post

Is Weed Legal in New Orleans? Here’s Everything You Need to Know

Whether you’re walking down Bourbon Street or chilling in one of the parks along the Mississippi River, chances are you’re going to encounter cannabis in the Big Easy. After all, New Orleans is a global mecca for having a good time. But despite the city’s…
Read
Random Post

Cannabis lounge coming to Bay City, Kokomo’s reopens as Press Play 989 and more business news

From a new cannabis consumption lounge coming to downtown Bay City to a family fun center that just reopened in Saginaw County, here’s some recent business news you might have missed: Little Pastry Shop bringing freshly-baked cinnamon rolls and pies…
Read
Random Post

‘Biggest thing, ever’: Marijuana rescheduling recommendation hailed

The disclosure Wednesday that top Biden administration health officials this week officially recommended marijuana be reclassified from a Schedule 1 substance to Schedule 3 – the same category as Tylenol with codeine – was hailed as the biggest development in MJ…
Read